Wound Care (Pharmacies) - EAEU

  • EAEU
  • Revenue in the Wound Care market is projected to reach US$70.52m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.09%, resulting in a market volume of US$70.78m by 2028.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.39 are generated in 2024.

Key regions: South Korea, United States, Canada, United Kingdom, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in EAEU is experiencing steady growth due to increasing customer preferences for advanced wound care products, emerging trends in the market, and favorable local special circumstances. Additionally, underlying macroeconomic factors are contributing to the development of the market.

Customer preferences:
Customers in the EAEU region are increasingly opting for advanced wound care products due to their effectiveness in promoting faster wound healing and reducing the risk of infections. These products, such as hydrocolloid dressings and foam dressings, are gaining popularity among consumers as they offer better wound management and improved patient comfort. Additionally, customers are seeking wound care products that are easy to use and provide long-lasting protection.

Trends in the market:
One of the key trends in the Wound Care (Pharmacies) market in EAEU is the growing demand for wound care products with antimicrobial properties. This trend is driven by the increasing prevalence of antibiotic-resistant infections, which has led to a greater emphasis on preventing and treating wound infections. As a result, products such as silver dressings and antimicrobial ointments are witnessing high demand in the market. Another trend in the market is the rising adoption of advanced wound care technologies, such as negative pressure wound therapy (NPWT) and bioactive dressings. These technologies offer superior wound healing outcomes and are increasingly being used in both acute and chronic wound management. The adoption of these advanced technologies is driven by the growing awareness among healthcare professionals and patients about their benefits.

Local special circumstances:
The Wound Care (Pharmacies) market in EAEU is benefiting from favorable local circumstances, such as an aging population and an increasing prevalence of chronic diseases. As the population ages, the incidence of chronic wounds, such as diabetic ulcers and pressure ulcers, is on the rise. This has created a significant demand for wound care products in the region. Furthermore, the EAEU region has witnessed an increase in healthcare expenditure, leading to improved access to healthcare services. This has resulted in a greater availability of wound care products in pharmacies, making it easier for customers to access the products they need.

Underlying macroeconomic factors:
The development of the Wound Care (Pharmacies) market in EAEU is also influenced by underlying macroeconomic factors. The region has been experiencing steady economic growth, which has led to increased disposable income among consumers. This, in turn, has contributed to the growing demand for healthcare products, including wound care products. Moreover, the EAEU region has been focusing on healthcare reforms and investments in healthcare infrastructure, which have improved the overall healthcare system. These reforms have led to better healthcare services and increased access to wound care products, driving the growth of the market. In conclusion, the Wound Care (Pharmacies) market in EAEU is developing due to customer preferences for advanced wound care products, emerging trends in the market, favorable local circumstances, and underlying macroeconomic factors. The increasing demand for advanced wound care technologies and antimicrobial products, along with the aging population and rising healthcare expenditure, are driving the growth of the market in the region.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)